Lynx1 Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lynx1 Capital Management LP
CRD #310301
SEC #801-127585
CIK #0001910456
AUM $136.4 MM (2023-03-03)
Employees 3 (100% Investors, 0% Brokers)
Phone703-963-7214
Address151 Calle de San Francisco
San Juan, PR 00901
Source [IAPD] [EDGAR]
Total AUM ($MM)
14011284562802010201420192024
Sector Form 13F Holdings Cap ($MM) Value ($MM)
ALPN 244.1 24.2
CABA 30.1 20.3
MRUS 941.6 19.6
KNTE 571.7 13.8
CBAY 232.0 11.9
PIRS 148.2 6.9
THRX 205.9 6.8
BLU 1,001.3 6.2
PRDS 177.0 4.4
PASG 128.2 3.3
View All
Holdings by Sector ($MM)
1209672482402020202120222024
Type Form D Funds Date Sold ($MM) AUM ($MM)
PE Lynx1 Opportunity Fund I LP 2023-03-03 10.1
HF Lynx1 Master Fund LP [2021-10-13] 124.0 126.3
AUM Breakdown Accounts AUM ($MM)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 136.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 136.4
By Discretionary
Discretionary 3 136.4
Non-Discretionary 0 0.0
Total 3 136.4
By Non-United States Persons
Non-United States Persons 126.3
United States Persons 10.1
Total 3 136.4
Form D Directors # Filings # Firms 2011 - 2023
Weston Nichols 2
Lynx1 Fund GP LLC 1
Lynx1 Capital Management LP 1
EDGAR Form CIK 2011 - 2023
13F-HR [0001910456]
3 [0001910456]
4 [0001910456]
SC 13G [0001910456]
Form 13D/13G Filer Form 13D/13G Subject Filed
Lynx1 Capital Management LP TScan Therapeutics Inc [2023-06-02]
Lynx1 Capital Management LP Kinnate Biopharma Inc [2023-01-23]
Lynx1 Capital Management LP Pardes Biosciences Inc [2023-01-23]
Lynx1 Capital Management LP Neoleukin Therapeutics Inc [2022-12-30]
Lynx1 Capital Management LP Cabaletta Bio Inc [2022-10-31]
Lynx1 Capital Management LP Pieris Pharmaceuticals Inc [2022-10-24]
Lynx1 Capital Management LP Passage Bio Inc [2022-09-29]
Lynx1 Capital Management LP Alpine Immune Sciences Inc [2022-04-22]
Form 3/4/5 Subject 2011 - 2023
Lynx1 Capital Management LP
TScan Therapeutics, Inc.
Nichols Weston
Comparable Firms State AUM ($BB)
Navy Capital Green Management LLC
CT 0.2
Totem Point Management LLC
NY 0.2
Ortelius Capital Partners LLC
NY 0.2
Tano Capital LLC
CA 0.1
Manikay Partners LLC
NY 0.1
1207 Capital Group LLC
IL 0.1
Kelly Park Investment LLC
NY 0.1
Proteus LLC
IN 0.1
S Muoio & Co LLC
NY 0.1
Stonebridge Partners LLC
NY 0.1
Terms | Privacy | Guide
tony@aum13f.com